Christopher M. Tarney

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Sexual harassment and gender discrimination in gynecologic oncology”.

Sexual harassment and gender discrimination in gynecologic oncology

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.08.014

N/A

0DataRank · unranked

20 citations

Christopher M. Tarney, Kenneth Seier, Yovanni Casablanca, Carol L. Brown, Marina Stasenko

Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.009

N/A

0DataRank · unranked

9 citations

Chunqiao Tian, Yovanni Casablanca, Nicholas W. Bateman, Suzanne Jokajtys, Calen Kucera +20 more

Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.026

N/A

0DataRank · unranked

6 citations

Chunqiao Tian, Jordyn Tumas, Neil T. Phippen, Christopher M. Tarney, Erica Hope +22 more

Lynch Syndrome in Focus: A Multidisciplinary Review of Cancer Risk, Clinical Management, and Special Populations

Cancers(2025)10.3390/cancers17243981

N/A

0DataRank · unranked

4 citations

Ilhan Birsenogul, Ashley Bowen, J Doyle, Stephen E. Pupkin, Joaquín Villar +5 more

Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statement

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.09.010

N/A

0DataRank · unranked

1 citations

Ira Winer, Christopher M. Tarney, Stéphanie Gaillard, Roisin E. O’Cearbhaill, Charles A. Powell

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA -deficient tubo-ovarian high-grade serous carcinoma

medRxiv(2025)10.1101/2025.09.17.25335919

N/A

0DataRank · unranked

0 citations

Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana, Laura Twomey +95 more

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.094

N/A

0DataRank · unranked

0 citations

Danielle Enserro, Heather A. Lankes, Kyle C. Strickland, Rebecca A. Previs, Matthew Powell +19 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

Research Square(2025)10.21203/rs.3.rs-7572112/v1

N/A

0DataRank · unranked

0 citations

Tibor A. Zwimpfer, Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana +95 more